Chembio Diagnostics is a biotech firm based in Hauppauge, New York that develops powerful diagnostic tools for medical applications the world over. The company keeps a global network of offices to ...

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! The worst result, after buying shares in a company (assuming no leverage), ...

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...

Readers may recall April 5 as the day that Chembio announced it had commercially launched a rapid test. This test was granted emergency-use authorization (EUA) by the U.S. Food and Drug Administration ...

Statistically speaking, long term investing is a profitable endeavour. But along the way some stocks are going to perform badly. For example the Chembio Diagnostics, Inc. (NASDAQ:CEMI) share price ...

Phase 3 randomized trial (KEYNOTE-630) of adjuvant pembrolizumab (pembro) versus placebo (pbo) for high-risk locally advanced cutaneous squamous cell carcinoma (LA cSCC) following surgery and ...